Clinical trial

Bone Marrow-derived Mesenchymal Stem Cells (MSC) Administration in Weaning From Left Ventricular Assist Device

NCT02460770

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2015-06-01

PhasePHASE1

Study timeline

Study start (estimated)2015-06-01Date precision: month

Registry last updated2018-01-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Myocardial Ischemiaunresolved

Interventions

Autologous mesenchymal stem cellsDRUG

Sponsors & collaborators

University Hospital, Toulouselead sponsor

Thoratec Corporationcollaborator

Mapped research locations

ToulouseFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02460770 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.